Barbara Ryan
Director · MiNK Therapeutics, Inc.
Individual
- 2024
- Sep 2, 2026
- 16
Other insiders active in the same sector
No other insider has filed at Barbara Ryan's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- Roger Adsett - $47.51M in INSM purchases and sales in the last 12 months
- Brian Taylor Slingsby - $46.36M in MLYS purchases and sales in the last 12 months
- Matthew Gline - $46.17M in ROIV purchases and sales in the last 12 months
- Larry Robbins - $46.04M in BFLY purchases and sales in the last 12 months
- R01 Fund LP - $45.65M in SDEV purchases and sales in the last 12 months
- Michael John Kazley - $45.65M in SDEV purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Barbara Ryan?
Barbara Ryan is a corporate insider, tracked as Director of MiNK Therapeutics, Inc. (INKT). InsiderAlpha holds 16 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Barbara Ryan submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Barbara Ryan been buying or selling stock?
Recorded transactions: 2 open-market purchases ($1K) and 8 open-market sales ($47K) across all tracked filings.
